Immunovant
Immunovant's email is info@immunovant.com
.
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Its investigational product candidate, IMVT-1401 (formerly known as RVT-1401), is a novel, fully human monoclonal antibody targeting the neonatal Fc receptor (FcRn). We believe that this product has the potential to address a variety of IgG-mediated autoimmune diseases as a subcutaneous injection.
View Top Employees for Immunovant
|
Website | immunovant.com |
|
Industry | Biotechnology |
|
Location | New York, United States |
|
Employees | 56 |
|
Founded | 2018 |
|
HQ | 151 W 42nd Street 15th Floor |
|
info@immunovant.com | |
|
Funding | 200,000,000 USD |
|
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
|
|
Website | immunovant.com |
|
|
Industry | Biotechnology |
|
|
Location | New York, United States |
|
|
Employees | 56 |
|
|
Founded | 2018 |
|
linkedin.com/company/immunovant | |
|
|
HQ | 151 W 42nd Street 15th Floor |
|
|
info@immunovant.com | |
|
|
Funding | 200,000,000 USD |
Email Patterns for Immunovant
Top Competitors for Immunovant
Immunovant Questions
Where are Immunovant's headquarters?
Immunovant's headquarters are in 151 W 42nd Street 15th Floor
What is Immunovant's official website?
Immunovant's website is immunovant.com
How many employees are working in Immunovant right now?
Immunovant has
56 employees.
View the Email and Phone Numbers for all 56 working at Immunovant.
What is Immunovant's industry?
Immunovant's industry is
Biotechnology
Who are Immunovant's top competitors?
Immunovant's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Immunovant's email address?
Immunovant's email address is info@immunovant.com
What are Immunovant's categories?
Immunovant's categories are Biotechnology, Pharmaceutical
What is Immunovant's location?
Immunovant's location is
New York, United States
When was Immunovant's founded?
Immunovant's founding year is 2018
What is Immunovant's funding?
Immunovant's funding is 200,000,000 USD
What is Immunovant's current status?
Immunovant's current status is ipo
Top Immunovant Employees
Director Cmc Program Management
amishapatel12345@yahoo.com
+1908-200-7500
Senior Manager, Human Resources Operations
cpalermo@fifthstreetfinance.com
+1203-681-3600
Clinical Trial Assistant
slterry@email.unc.edu
+1919-280-3102
Independent Director
gmigausky@dyax.com
+1617-250-5733
Accounting Senior Manager
akramy@gmail.com
+1201-500-8101
Vice President, Head Of Quality
annmariedaus@comcast.net
+1201-883-5300
Vice President, Global Program And Alliance Management
jyotin.vyas@bms.com
+1212-573-3115
